Cargando…

GUCY2C at the intersection of obesity and colorectal cancer

Detalles Bibliográficos
Autores principales:	Waldman, Scott A, Lin, Jieru E, Colon-Gonzalez, Francheska, Snook, Adam, Valentino, Michael, Kim, Gilbert, Blomain, Erik, Hyslop, Theresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765502/ http://dx.doi.org/10.1186/2050-6511-14-S1-O28

Ejemplares similares

GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity
por: Lin, Jieru Egeria, et al.
Publicado: (2012)

APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis
por: Blomain, Erik S., et al.
Publicado: (2020)

GUCY2C-targeted chimeric antigen receptor expressing T cells extend survival in a therapeutic mouse model of metastatic colorectal cancer
por: Magee, Michael S, et al.
Publicado: (2013)

A Phase I study of AD5-GUCY2C-PADRE in stage I and II colon cancer patients
por: Snook, Adam, et al.
Publicado: (2015)

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
por: Marszalowicz, Glen P., et al.
Publicado: (2014)

Hormone suppression silencing GUCY2C is required for colorectal cancer
por: Waldman, Scott A
Publicado: (2015)

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
por: Magee, Michael S., et al.
Publicado: (2016)

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
por: Cheslow, Lara, et al.
Publicado: (2023)

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
por: Snook, Adam E., et al.
Publicado: (2019)

GUCY2C maintains intestinal LGR5(+) stem cells by opposing ER stress
por: Kraft, Crystal L., et al.
Publicado: (2017)

Intestinal neuropod cell GUCY2C regulates visceral pain
por: Barton, Joshua R., et al.
Publicado: (2023)

Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity
por: Pattison, Amanda M., et al.
Publicado: (2020)

A Novel CDX2 Isoform Regulates Alternative Splicing
por: Witek, Matthew E., et al.
Publicado: (2014)

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer
por: Rappaport, Jeffrey A., et al.
Publicado: (2021)

ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice
por: Li, Peng, et al.
Publicado: (2017)

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy
por: Merlino, Dante J., et al.
Publicado: (2014)

Mechanisms of Weight Regain following Weight Loss
por: Blomain, Erik Scott, et al.
Publicado: (2013)

Anosognosia and schizophrenia: the ethical intersection of insight, treatment and coercion
por: Marley, James
Publicado: (2007)

Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
por: Rampuria, Pragya, et al.
Publicado: (2023)

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
por: Flickinger Jr, John C, et al.
Publicado: (2020)

Synergistic DNA-adenovirus prime-boost immunization eliminates metastatic colorectal cancer by inducing high avidity effector CD8+ T cells
por: Xiang, Bo, et al.
Publicado: (2014)

Guanylyl cyclase C signaling axis and colon cancer prevention
por: Pattison, Amanda M, et al.
Publicado: (2016)

Failure to comply with the law of freedom of right turn at intersections by drivers and its impact on the equation of Cost -benefit and the behavioral architecture of a Healthy City
por: Hekmatshoar, Reza, et al.
Publicado: (2019)

Molecular Staging of Node Negative Patients with Colorectal Cancer
por: Hyslop, Terry, et al.
Publicado: (2013)

Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer
por: Neklason, Deborah W, et al.
Publicado: (2010)

Mechanisms of autoimmunity in mice lacking the mer membrane tyrosine kinase
por: Cohen, PL, et al.
Publicado: (2004)

Screening & staging of colorectal cancer
por: Schima, Wolfgang, et al.
Publicado: (2014)

Targeting mutant BRAF in colorectal cancer
por: Carroll, David, et al.
Publicado: (2013)

Is leptin the link between obesity and osteoarthritis?
por: Pottie, P, et al.
Publicado: (2004)

Reconsidering the policy options to combat obesity
por: Ferguson, Christine
Publicado: (2012)

Targeting KIT on innate immune cells enhances the antitumor activity of checkpoint inhibitors in vivo
por: Gedrich, Richard, et al.
Publicado: (2015)

The comparative genetics and genomics of cancer: of mice and men
por: Hodgson, G, et al.
Publicado: (2003)

The prevalence of obesity in mature Icelandic horses in Denmark
por: Jensen, Rasmus Bovbjerg, et al.
Publicado: (2015)

Adjuvant therapy in colorectal cancer – studies of the FOGT group
por: Staib, Ludger, et al.
Publicado: (2010)

Feasibility and prognostic value of stress-perfusion CMR in obesity
por: Shah, Ravi, et al.
Publicado: (2012)

Obesity, insulin resistance, and the pathway to type 2 diabetes
por: Bergman, Richard N
Publicado: (2012)

Nutritional genomics and metabolomics in obesity and type 2 diabetes
por: Hu, Frank B, et al.
Publicado: (2014)

Hyperpolarized (13)C and (31)P magnetic resonance spectroscopy identify pyruvate dehydrogenase as a therapeutic target in obesity cardiomyopathy
por: Lewis, Andrew J, et al.
Publicado: (2015)

Colorectal cancer in hyperplastic polyposis syndrome: In search of the polyp of origin
por: Rosty, Christophe, et al.
Publicado: (2011)

Microsatellite instability in colorectal adenomas and hyperplastic polyps in Lynch syndrome
por: Yurgelun, Matthew B, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qo2ic0d18gr731adn68bo0drv0